Delivery Order SPE2DR25D3103-SPE2DR26F0M1V
- Not listed
- The Defense Logistics Agency awarded a $35,976.13 delivery order to AmerisourceBergen Drug Corp on November 18, 2025, for the supply of Enbrel 50 mg/ml syringes. This is a firm fixed-price, non-set-aside contract with a completion date of November 19, 2025, and performance taking place at the vendor's corporate office in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999...
- The Defense Logistics Agency has awarded a $28,527.66 delivery order to AmerisourceBergen Drug Corp for the supply of Enbrel 50 mg/mL syringes, with performance at the contractor's facility in Conshohocken, Pennsylvania. This competitively awarded, firm fixed-price delivery order is scheduled for completion by December 10, 2025. The award represents a child delivery order under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a...
- <p>The Defense Logistics Agency issued a $22,133.99 delivery order to Amerisourcebergen Drug Corp on April 16, 2026, for ENBREL 50 MG/ML syringes with an ultimate completion date of April 17, 2026.</p> <p>The order is issued under a Defense Logistics Agency indefinite delivery contract supporting pharmaceutical supply to the Department of Defense and federal healthcare systems. Place of performance is Conshohocken, PA. Pricing is firm fixed price with no set-aside applied.</p>
- The Defense Logistics Agency awarded a $17,257.88 delivery order to AmerisourceBergen Drug Corp on June 9, 2025, for the supply of Enbrel 50 mg/ml syringes. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $10,289.30 to Amerisourcebergen Drug Corporation. Under the contract, Amerisourcebergen will provide 50 mg/ml syringes of the drug Enbrel to support the Defense Logistics Agency's medical supply needs. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period from July 20 to July 21, 2023. As a top pharmaceutical distributor, Amerisourcebergen will leverage its...
- The Defense Logistics Agency awarded a $16,622.35 delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Enbrel 50 mg/ml syringes. This firm fixed-price, non-competitive delivery order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 10, 2025. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a $5,504.80 firm fixed price delivery order to AmerisourceBergen Drug Corp for Enbrel 50 mg/ml syringes, with an ultimate completion date of August 19, 2025. This non-set-aside contract represents a direct award to the pharmaceutical distributor, which maintains its corporate office in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999...
- The Defense Logistics Agency issued a $5,923.00 delivery order to Amerisourcebergen Drug Corp on April 17, 2026, for ENBREL 25 MG/0.5 ML vials. The order carries a firm fixed-price structure with an ultimate completion date of April 20, 2026. Place of performance is Conshohocken, PA. The order was issued under a DLA Troop Support Medical indefinite delivery contract supporting pharmaceutical supply to military healthcare systems. Amerisourcebergen Drug Corp operates as a subsidiary of Cencora,...
- The Defense Logistics Agency awarded a $14.5K delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of ENBREL 25 mg/0.5 ml syringes. This firm fixed-price, competitively awarded contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The product will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency issued a $29,343.39 delivery order to Amerisourcebergen Drug Corp on April 17, 2026, for ENBREL 50 mg/ml SureClick pharmaceutical product with an ultimate completion date of April 20, 2026. Place of performance is Conshohocken, PA. The order is firm fixed-price with no set-aside. Amerisourcebergen, a subsidiary of Cencora, Inc., is a pharmaceutical distributor supplying brand-name and generic medications, specialty pharmaceuticals, and medical devices to the...
- SPE2DR25D3103Indefinite Delivery Contract
- SPE2DR25D3103-SPE2DR26F0M1VDelivery Order
The Defense Logistics Agency issued a $21,245.66 delivery order to AmerisourceBergen Drug Corp on April 17, 2026, for Enbrel 50 mg/ml syringes under a firm fixed-price award with an ultimate completion date of April 20, 2026. Place of performance is Conshohocken, PA. AmerisourceBergen operates as a pharmaceutical distributor supplying brand-name and generic medications, specialty pharmaceuticals, and medical devices to Defense Health Agency and military medical facilities globally. The company holds a single-award indefinite delivery contract (SPE2DX) with the Defense Logistics Agency valued at $4.999 million through December 2036, supporting the Pharmaceutical Prime Vendor Global Program Generation V for worldwide military healthcare supply.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $21.2k | 4/16/26 |